InvestorsHub Logo
Followers 17
Posts 936
Boards Moderated 0
Alias Born 04/26/2010

Re: loanranger post# 241508

Tuesday, 09/18/2018 1:19:38 PM

Tuesday, September 18, 2018 1:19:38 PM

Post# of 403047
Thanks LR. I am bit surprised of Penn not being overtly greedy. Otherwise, section 5.3.2 and 'Trigger Events' seems to be part of Penn standard patent license agreement. At least Aegerion Pharmaceuticals has similar language in their agreement with Penn:

https://www.sec.gov/Archives/edgar/data/1338042/000119312510184678/dex106.htm

As does Sparks Therapeutics:

https://www.lawinsider.com/contracts/4QSLK2FqxkFEt8Jjpc73cs/spark-therapeutics-inc/1609351/2014-12-11

"I would rather have questions that can't be answered than answers that can't be questioned." Richard P. Feynman

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News